Medicare’s prescription-drug program may save billions of {dollars} yearly if it bought generic acid-reflux, most cancers and different medicine from a brand new pharmacy backed by investor Mark Cuban, in response to Harvard Medical College researchers.
Mr. Cuban, the billionaire web entrepreneur and proprietor of the NBA’s Dallas Mavericks, launched his pharmacy in January with an eye fixed towards disrupting the $365 billion U.S. prescription-drug market by sidestepping health-insurers and promoting generally used generic medicines on to customers with a clear, fixed-rate markup pricing mannequin.
